Yahoo
NasdaqCM - Delayed Quote USD

Nutriband Inc. (NTRB)

5.55 -0.02 (-0.45%)
At close: November 6 at 4:00:00 PM EST

Key Executives

Amounts are as of December 31, 2026 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Serguei Melnik
Founder, President, Company Secretary & Executive Chairman 542.11k -- 1974
Mr. Gareth Sheridan
Founder, CEO & Director 542.11k -- 1990
Mr. Gerald Goodman
CFO & Chief Accounting Officer 147.67k -- 1948
Dr. Alan Smith Ph.D.
COO & President of 4P Therapeutics 161.67k -- 1966
Dr. Jeffrey Patrick Pharm.D.
Chief Scientific Officer -- -- 1970
Mr. Michael Myer
President of Pocono Pharmaceutical 40.6k -- 1984
Mr. Tyler Overk
Head of Active Intelligence -- -- 1984

Nutriband Inc.

121 South Orange Avenue
Suite 1500
Orlando, FL 32801
United States
407 377 6695 https://www.nutriband.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Corporate Governance

Nutriband Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

September 30, 2026 at 12:00 AM UTC

25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured

September 23, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 4, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

June 22, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 11, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 18, 2026 at 12:00 AM UTC

10-K/A: Periodic Financial Reports

April 29, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

April 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 3, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 30, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: